UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2010
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission file number 1-442
THE BOEING COMPANY
(Exact name of
registrant as specified in its charter)
Delaware
91-0425694
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)
100
N. Riverside Plaza, Chicago, IL 60606-1596
(Address of principal executive offices, including zip code)
(312) 544-2000
(Registrant s
telephone number, including area code)
(Former name, former
address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the
definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated
filer
Accelerated filer
Non-accelerated
filer (Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
No
As of April 16, 2010, there were 759,036,516 shares of common stock, $5.00 par value, issued and outstanding.
(This number includes 30 million outstanding shares held by the ShareValue Trust which are not eligible to vote.)
Table of Contents
THE BOEING COMPANY
FORM 10-Q
For the Quarter
Ended March 31, 2010
INDEX
Page
Part I. Financial Information (Unaudited)
Item 1.
Financial Statements
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Financial Position
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statement of Shareholders Equity
Summary of Business Segment Data
Note 1 Basis of Presentation
Note 2 Earnings Per Share
Note 3 Income Taxes
Note 4 Inventories
Note 5 Investments
Note 6 Liabilities, Commitments and Contingencies
Note 7 Arrangements with Off-Balance Sheet Risk
12
Note 8 Postretirement Plans
14
Note 9 Share-Based Compensation and Other Compensation Arrangements
14
Note 10 Derivative Financial Instruments
15
Note 11 Fair Value Measurements
17
Note 12 Legal Proceedings
18
Note 13 Business Segment Data
23
Report of Independent Registered Public Accounting Firm
25
Forward-Looking Information Is Subject to Risk and Uncertainty
26
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
27
Consolidated Operating Results
27
Commercial Airplanes
30
Boeing Defense, Space & Security
33
Boeing Capital Corporation
38
Other Segment
39
Liquidity and Capital Resources
40
Off-Balance Sheet Arrangements
41
Contingent Obligations
41
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
42
Item 4.
Controls and Procedures
42
Part II. Other Information
Item 1.
Legal Proceedings
43
Item 1A.
Risk Factors
43
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
43
Item 6.
Exhibits
44
Signature
45
Exhibit (15) Letter from Independent Registered Public Accounting Firm Regarding Unaudited Interim Financial
Information
46
Exhibit (31)(i) CEO Section 302 Certification
47
Exhibit (31)(ii) CFO Section 302 Certification
48
Exhibit (32)(i) CEO Section 906 Certification
49
Exhibit (32)(ii) CFO Section 906 Certification
50
Table of Contents
Part I. Financial Information
Item 1. Financial Statements
The Boeing Company and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollars in millions, except per share data)
Three months ended
March 31
2010
2009
Sales of products
12,316
13,835
Sales of services
2,900
2,667
Total revenues
15,216
16,502
Cost of products
(9,822
(11,579
Cost of services
(2,281
(2,119
Boeing Capital Corporation interest expense
(41
(47
Total costs and expenses
(12,144
(13,745
3,072
2,757
Income from operating investments, net
59
32
General and administrative expense
(953
(791
Research and development expense, net
(1,000
(970
Loss on dispositions, net
(4
(3
Earnings from operations
1,174
1,025
Other expense, net
(2
(36
Interest and debt expense
(122
(57
Earnings before income taxes
1,050
932
Income tax expense
(531
(317
Net earnings from continuing operations
519
615
Net loss on disposal of discontinued operations, net of taxes of $3
(5
Net earnings
519
610
Basic earnings per share from continuing operations
0.71
0.88
Net loss on disposal of discontinued operations, net of taxes
(0.01
Basic earnings per share
0.71
0.87
Diluted earnings per share from continuing operations
0.70
0.87
Net loss on disposal of discontinued operations, net of taxes
(0.01
Diluted earnings per share
0.70
0.86
Cash dividends paid per share
0.42
0.42
Weighted average diluted shares (millions)
740.1
707.4
See Notes to Condensed Consolidated Financial Statements.
Table of Contents
The Boeing Company and Subsidiaries
Condensed Consolidated Statements of Financial Position
(Unaudited)
(Dollars in millions, except per share data)
March 31
2010
December 31
2009
Assets
Cash and cash equivalents
4,517
9,215
Short-term investments
5,845
2,008
Accounts receivable, net
6,359
5,785
Current portion of customer financing, net
274
368
Deferred income taxes
1,030
966
Inventories, net of advances and progress billings
18,773
16,933
Total current assets
36,798
35,275
Customer financing, net
5,273
5,466
Property, plant and equipment, net of accumulated depreciation of $13,028 and $12,795
8,693
8,784
Goodwill
4,317
4,319
Other acquired intangibles, net
2,878
2,877
Deferred income taxes
2,754
3,062
Investments
1,030
1,030
Pension plan assets, net
21
16
Other assets, net of accumulated amortization of $441 and $492
1,206
1,224
Total assets
62,970
62,053
Liabilities and shareholders equity
Accounts payable
7,469
7,096
Other accrued liabilities
12,267
12,822
Advances and billings in excess of related costs
11,857
12,076
Income taxes payable
412
182
Short-term debt and current portion of long-term debt
1,479
707
Total current liabilities
33,484
32,883
Accrued retiree health care
7,043
7,049
Accrued pension plan liability, net
6,392
6,315
Non-current income taxes payable
896
827
Other long-term liabilities
652
537
Long-term debt
11,464
12,217
Shareholders equity:
Common shares issued, par value $5.00 1,200,000,000 authorized; 1,012,261,159 shares issued
5,061
5,061
Additional paid-in capital
4,264
3,724
Treasury shares, at cost 253,748,666 and 256,406,709 shares
(15,744
(15,911
Retained earnings
23,265
22,746
Accumulated other comprehensive loss
(11,747
(11,877
ShareValue Trust shares 29,747,123 and 29,563,324
(2,157
(1,615
Total Boeing shareholders equity
2,942
2,128
Noncontrolling interest
97
97
Total shareholders equity
3,039
2,225
Total liabilities and shareholders equity
62,970
62,053
See Notes to Condensed Consolidated Financial Statements.
Table of Contents
The Boeing Company and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollars in millions)
Three months ended
March 31
2010
2009
Cash flows operating activities:
Net earnings
519
610
Adjustments to reconcile net earnings to net cash (used)/provided by operating activities:
Non-cash items
Share-based plans expense
66
60
Depreciation
350
335
Amortization of other acquired intangibles
55
49
Amortization of debt discount/premium and issuance costs
Investment/asset impairment charges, net
15
21
Customer financing valuation provision
12
Loss on disposal of discontinued operations
Loss on dispositions, net
Other charges and credits, net
30
63
Excess tax benefits from share-based payment arrangements
(8
(5
Changes in assets and liabilities
Accounts receivable
(572
(869
Inventories, net of advances and progress billings
(1,833
(82
Accounts payable
225
644
Other accrued liabilities
(136
(169
Advances and billings in excess of related costs
(221
(1,210
Income taxes receivable, payable and deferred
429
534
Other long-term liabilities
246
(51
Pension and other postretirement plans
355
304
Customer financing, net
221
21
Other
(47
(84
Net cash (used)/provided by operating activities
(285
193
Cash flows investing activities:
Property, plant and equipment additions
(186
(442
Property, plant and equipment reductions
25
Acquisitions, net of cash acquired
(24
(30
Contributions to investments
(4,744
(200
Proceeds from investments
910
49
Net cash used by investing activities
(4,041
(598
Cash flows financing activities:
New borrowings
19
1,827
Debt repayments
(51
(71
Repayments of distribution rights financing
(13
Stock options exercised, other
23
Excess tax benefits from share-based payment arrangements
Employee taxes on certain share-based payment arrangements
(15
(15
Common shares repurchased
(50
Dividends paid
(318
(305
Net cash (used)/provided by financing activities
(347
1,391
Effect of exchange rate changes on cash and cash equivalents
(25
(17
Net (decrease)/increase in cash and cash equivalents
(4,698
969
Cash and cash equivalents at beginning of year
9,215
3,268
Cash and cash equivalents at end of period
4,517
4,237
See Notes to Condensed Consolidated Financial Statements.
Table of Contents
The Boeing Company and Subsidiaries
Condensed Consolidated Statement of Shareholders Equity
(Unaudited)
Boeing shareholders
(Dollars in millions, except per
share data)
Common
Stock
Additional
Paid-In
Capital
Treasury
Stock
Share-
Value
Trust
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Non-
controlling
Interest
Total
Balance January 1, 2009
5,061
3,456
($
17,758
($
1,203
22,675
($
13,525
152
($
1,142
Net earnings
610
611
Unrealized loss on derivative instruments, net of tax of $26
(45
(45
Unrealized loss on certain investments, net of tax of $9
(14
(14
Reclassification adjustment for losses realized in net earnings, net of tax of $(5)
Currency translation adjustment
(29
(29
Postretirement liability adjustment, net of tax of $(73)
94
94
Comprehensive income
625
Share-based compensation and related dividend equivalents
63
(1
62
ShareValue Trust activity
(174
174
Excess tax pools
Treasury shares issued for other share-based plans, net
(57
52
(5
Treasury shares repurchased
(50
(50
Balance March 31, 2009
5,061
3,289
($
17,756
($
1,029
23,284
($
13,511
153
($
509
Balance January 1, 2010
5,061
3,724
($
15,911
($
1,615
22,746
($
11,877
97
2,225
Net earnings
519
519
Unrealized loss on derivative instruments, net of tax of $5
(9
(9
Reclassification adjustment for gains realized in net earnings, net of tax of $2
(4
(4
Currency translation adjustment
(40
(40
Postretirement liability adjustment, net of tax of $(113)
183
183
Comprehensive income
649
Share-based compensation and related dividend equivalents
66
66
ShareValue Trust activity
542
(542
Excess tax pools
(11
(11
Treasury shares issued for stock options exercised, net
(14
38
24
Treasury shares issued for other share-based plans, net
(45
36
(9
Treasury shares issued for 401(k) contribution
93
95
Balance March 31, 2010
5,061
4,264
($
15,744
($
2,157
23,265
($
11,747
97
3,039
See Notes to Condensed Consolidated Financial Statements.
Table of Contents
The Boeing Company and Subsidiaries
Notes to Condensed Consolidated Financial Statements
Summary of Business Segment Data
(Unaudited)
(Dollars in millions)
Three months ended
March 31
2010
2009
Revenues:
Commercial Airplanes
7,468
8,554
Boeing Defense, Space & Security:
Boeing Military Aircraft
3,241
3,067
Network & Space Systems
2,323
2,678
Global Services & Support
2,049
1,975
Total Boeing Defense, Space & Security
7,613
7,720
Boeing Capital Corporation
162
163
Other segment
36
39
Unallocated items and eliminations
(63
26
Total revenues
15,216
16,502
Earnings from operations:
Commercial Airplanes
679
417
Boeing Defense, Space & Security:
Boeing Military Aircraft
267
288
Network & Space Systems
174
207
Global Services & Support
223
214
Total Boeing Defense, Space & Security
664
709
Boeing Capital Corporation
46
37
Other segment
(50
(23
Unallocated items and eliminations
(165
(115
Earnings from operations
1,174
1,025
Other expense, net
(2
(36
Interest and debt expense
(122
(57
Earnings before income taxes
1,050
932
Income tax expense
(531
(317
Net earnings from continuing operations
519
615
Net loss on disposal of discontinued operations, net of taxes of $3
(5
Net earnings
519
610
Research and development expense, net:
Commercial Airplanes
698
711
Boeing Defense, Space & Security:
Boeing Military Aircraft
162
139
Network & Space Systems
106
86
Global Services & Support
34
25
Total Boeing Defense, Space & Security
302
250
Other segment
Total research and development expense, net
1,000
970
This information is an integral part of the Notes to Condensed Consolidated Financial Statements. See Note 13 for further segment
results.
Table of Contents
The Boeing Company and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Dollars in millions, except per share data)
(Unaudited)
Note 1
Basis of Presentation
The condensed consolidated interim financial statements included in this report have been prepared by management of The
Boeing Company (herein referred to as Boeing , the Company , we , us , or our ). In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary for a fair
presentation are reflected in the interim financial statements. The results of operations for the period ended March 31, 2010, are not necessarily indicative of the operating results for the full year. The interim financial statements should be
read in conjunction with the audited consolidated financial statements, including the notes thereto included in our 2009 Annual Report on Form 10-K. Certain amounts have been reclassified to conform to the current period s presentation.
Note 2 Earnings Per Share
The weighted average number of shares outstanding used to compute earnings per share were as follows:
(Shares in millions)
Three months ended
March 31
2010
2009
Weighted average shares outstanding
731.1
701.9
Participating securities
3.7
3.4
Basic weighted average shares outstanding
734.8
705.3
Dilutive potential common shares
5.3
2.1
Diluted weighted average shares outstanding
740.1
707.4
Basic earnings per share is calculated by the sum of (1) net
earnings less declared dividends and dividend equivalents related to share-based compensation divided by the basic weighted average shares outstanding and (2) declared dividends and dividend equivalents related to share-based compensation
divided by the weighted average shares outstanding.
The weighted average number of shares outstanding, included in the table below, was excluded from
the computation of diluted earnings per share because the average market price did not exceed the exercise/threshold price. However, these shares may be dilutive potential common shares in the future.
(Shares in millions)
Three months ended
March 31
2010
2009
Stock options
18.0
23.1
ShareValue Trust
13.3
12.9
Performance Awards
3.0
5.9
Performance Shares
0.8
Stock units
0.3
Table of Contents
Note 3 Income Taxes
The effective tax rates were 50.6% and 34.0% for the three months ended March 31, 2010 and 2009. The increase in the effective tax rate as compared with the
prior year was primarily due to an income tax charge of $150 recorded during the first quarter of 2010 as a result of the Patient Protection and Affordable Care Act, as modified by the Health Care and Education Reconciliation Act of 2010. As a
result of this legislation, beginning in 2013, we will no longer be able to claim an income tax deduction related to prescription drug benefits provided to retirees and reimbursed under the Medicare Part D retiree drug subsidy. The increase in the
effective tax rate was also due to U.S. research and development tax credit benefits that existed in 2009, but do not exist in 2010. The research and development tax credit reduced the 2009 tax rate by 3.2% in the first quarter of 2009.
The research and development credit expired on December 31, 2009. Congress is currently considering bills that will extend the credit. If the research and